Insider Transactions in Q3 2025 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,725
-5.61%
|
$394,500
$20.21 P/Share
|
|
Jul 17
2025
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,997
+2.5%
|
$35,988
$4.31 P/Share
|
|
Jul 16
2025
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-3.74%
|
$95,000
$19.55 P/Share
|
|
Jul 15
2025
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,900
-0.55%
|
$38,000
$20.09 P/Share
|
|
Jul 15
2025
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+0.23%
|
$3,200
$4.31 P/Share
|
|
Jul 14
2025
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
137,465
-28.59%
|
$2,749,300
$20.19 P/Share
|
|
Jul 14
2025
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,203
+11.94%
|
$260,812
$4.31 P/Share
|